Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenetix 300 in Pediatric MSCT
NCT00347022Phase 4Completed
- Sponsor
- Guerbet
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iobitridol, sponsored by Guerbet. Started May 2006; status: completed.
02
Drugs
iobitridol
Beyond the preview
Go deeper on NCT00347022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347022.